TrialDiabetologia2012

Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly.

A J Varewijck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.